Furthermore, studies on AD have demonstrated that continuous intraperitoneal injection of SEW2871 for two weeks leads to improved cognitive function in AD rats [57] and significantly reduces Tau-Ser262 phosphorylation [58]. Here, MAPT is linked to Alzheimer disease.